Chen, L., Wu, D., & Shen, Y. Fatty acid synthase inhibitor cerulenin hinders liver cancer stem cell properties through FASN/APP axis as novel therapeutic strategies. Elsevier.
Chicago Style (17th ed.) CitationChen, Liang-Yun, Dao-Sian Wu, and Yao-An Shen. Fatty Acid Synthase Inhibitor Cerulenin Hinders Liver Cancer Stem Cell Properties Through FASN/APP Axis as Novel Therapeutic Strategies. Elsevier.
MLA (9th ed.) CitationChen, Liang-Yun, et al. Fatty Acid Synthase Inhibitor Cerulenin Hinders Liver Cancer Stem Cell Properties Through FASN/APP Axis as Novel Therapeutic Strategies. Elsevier.
Warning: These citations may not always be 100% accurate.